Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

References

1. • Lopes R.D.
   • Pieper K.S.
   • Horton J.R.
   • Al-Khatib S.M.
   • Newby L.K.
   • Mehta R.H.
   • et al.
   Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
   Heart. 2008; 94: 867-873
   View in Article

   • Google Scholar
2. • Chan W.
   • Ajani A.E.
   • Clark D.J.
   • Stub D.
   • Andrianopoulos N.
   • Brennan A.L.
   • et al.
   Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention.
   Am J Cardiol. 2012; 109: 471-477
   View in Article

   • Google Scholar
3. • Choi H.-I.
   • Ahn J.-M.
   • Kang S.H.
   • Lee P.H.
   • Kang S.-J.
   • Lee S.-W.
   • et al.
   Prevalence, management, and long-term (6-year) outcomes of atrial fibrillation among patients receiving drug-eluting coronary stents.
   JACC Cardiovasc Interv. 2017; 10: 1075-1085
   View in Article

   • Google Scholar
4. • Chen J.
   • Wang L.Y.
   • Deng C.
   • Jiang X.-H.
   • Chen T.-G.
   The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis.
   Medicine (Baltimore). 2017; 96e8015
   View in Article

   • Google Scholar
5. • Mehran R.
   • Lansky A.J.
   • Witzenbichler B.
   • Guagliumi G.
   • Peruga J.Z.
   • Brodie B.R.
   • et al.
   Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
   Lancet. 2009; 374: 1149-1159
   View in Article

   • Google Scholar
6. • El-Omar M.M.
   • Dangas G.
   • Mehran R.
   • Lansky A.J.
   • Kipshidze N.N.
   • Polena S.
   • et al.
   Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention.
   Am J Cardiol. 2003; 91: 232-234
   View in Article

   • Google Scholar
7. • Sutton N.R.
   • Seth M.
   • Ruwende C.
   • Gurm H.S.
   Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention.
   J Am Coll Cardiol. 2016; 68: 895-904
   View in Article

   • Google Scholar
8. • Lip G.Y.
   • Keshishian A.
   • Kamble S.
   • Pan X.
   • Mardekian J.
   • Horblyuk R.
   • et al.
   Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis.
   Thromb Haemost. 2016; 116: 975-986
   View in Article

   • Google Scholar
9. • Zhang Y.
   • Zhang L.
   • Zheng H.
   • Chen H.
   Effects of atrial fibrillation on complications and prognosis of patients receiving emergency PCI after acute myocardial infarction.
   Exp Ther Med. 2018; 16: 3574-3578
   View in Article

   • Google Scholar
10. • Golwala H.B.
    • Cannon C.P.
    • Steg P.G.
    • Doros G.
    • Qamar A.
    • Ellis S.G.
    • et al.
    Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2018; 39: 1726-1735a
    View in Article

    • Google Scholar
11. • Granger C.B.
    • Alexander J.H.
    • McMurray J.J.V.
    • Lopes R.D.
    • Hylek E.M.
    • Hanna M.
    • et al.
    Apixaban versus warfarin in patients with atrial fibrillation.
    N Engl J Med. 2011; 365: 981-992
    View in Article

    • Google Scholar
12. • Connolly S.J.
    • Ezekowitz M.D.
    • Yusuf S.
    • Eikelboom J.
    • Oldgren J.
    • Parekh A.
    • et al.
    Dabigatran versus warfarin in patients with atrial fibrillation.
    N Engl J Med. 2009; 361: 1139-1151
    View in Article

    • Google Scholar
13. • Patel M.R.
    • Mahaffey K.W.
    • Garg J.
    • Pan G.
    • Singer D.E.
    • Hacke W.
    • et al.
    Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
    N Engl J Med. 2011; 365: 883-891
    View in Article

    • Google Scholar
14. • Andrianopoulos N.
    • Dinh D.
    • Duffy S.J.
    • Clark D.J.
    • Brennan A.L.
    • Chan W.
    • et al.
    Quality control activities associated with registries in interventional cardiology and surgery.
    Heart Lung Circ. 2011; 20: 180-186
    View in Article

    • Google Scholar
15. • Lagerqvist B.
    • James S.K.
    • Stenestrand U.
    • Landbäck J.
    • Nilsson T.
    • Wallentin L.
    • et al.
    Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
    N Engl J Med. 2007; 356: 1009-1019
    View in Article

    • Google Scholar
16. • Ajani A.E.
    • Szto G.
    • Duffy S.J.
    • Eccleston D.
    • Lefkovits J.
    • Chew D.P.
    • et al.
    The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project.
    Heart Lung Circ. 2006; 15: 44-47
    View in Article

    • Google Scholar
17. • Chan W.
    • Clark D.J.
    • Ajani A.E.
    • Yap C.-H.
    • Andrianopoulos N.
    • Brennan A.L.
    • et al.
    Progress towards a national cardiac procedure database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries.
    Heart Lung Circ. 2011; 20: 10-18
    View in Article

    • Google Scholar
18. • Lip G.Y.
    • Nieuwlaat R.
    • Pisters R.
    • Lane D.A.
    • Crijns H.G.J.M.
    Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey On Atrial Fibrillation.
    Chest. 2010; 137: 263-272
    View in Article

    • Google Scholar
19. • Ellis S.G.
    • Vandormael M.G.
    • Cowley M.J.
    • DiSciascio G.
    • Deligonul U.
    • Topol E.J.
    • et al.
    Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
    Circulation. 1990; 82: 1193-1202
    View in Article

    • Google Scholar
20. • Mehran R.
    • Rao S.V.
    • Bhatt D.L.
    • GIbson C.M.
    • Caixeta A.
    • Eikelboom J.
    • et al.
    Standardized Bleeding Definitions for Cardiovascular Clinical Trials.
    Circulation. 2011; 123: 2736-2747
    View in Article

    • Google Scholar
21. • Cutlip D.E.
    • Windecker S.
    • Mehran R.
    • Boam A.
    • Cohen D.J.
    • van Es G.-A.
    • et al.
    Clinical end points in coronary stent trials.
    Circulation. 2007; 115: 2344-2351
    View in Article

    • Google Scholar
22. • Matsuda Y.
    • Ishihara T.
    • Iida O.
    • Asai M.
    • Masuda M.
    • Okamoto S.
    • et al.
    Atrial fibrillation predicts long-term outcomes after percutaneous coronary intervention in patients with coronary artery disease.
    J Am Coll Cardiol. 2018; 71: A1027
    View in Article

    • Google Scholar
23. • Pilgrim T.
    • Kalesan B.
    • Zanchin T.
    • Pulver C.
    • Jung S.
    • Mattle H.
    • et al.
    Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.
    EuroIntervention. 2013; 8: 1061-1071
    View in Article

    • Google Scholar
24. • Benjamin E.J.
    • Wolf P.A.
    • D’Agostino R.B.
    • Silbershatz H.
    • Kannel W.B.
    • Levy D.
    Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
    Circulation. 1998; 98: 946-952
    View in Article

    • Google Scholar
25. • Mehra R.
    • Benjamin E.J.
    • Shahar E.
    • Gottlieb D.J.
    • Nawabit R.
    • Kirchner H.L.
    • et al.
    Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study.
    Am J Respir Crit Care Med. 2006; 173: 910-916
    View in Article

    • Google Scholar
26. • Chhatriwalla A.K.
    • Amin A.P.
    • Kennedy K.F.
    • House J.A.
    • Cohen D.J.
    • Rao S.V.
    • et al.
    Association between bleeding events and in-hospital mortality after percutaneous coronary intervention.
    JAMA. 2013; 309: 1022-1029
    View in Article

    • Google Scholar
27. • Kwok C.S.
    • Rao S.V.
    • Myint P.K.
    • Keavney B.
    • Nolan J.
    • Ludman P.F.
    • et al.
    Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis.
    Open Heart. 2014; 1e000021
    View in Article

    • Google Scholar
28. • Murali S.
    • Vogrin S.
    • Noaman S.
    • Dinh D.T.
    • Brennan A.L.
    • Lefkovits J.
    • et al.
    Bleeding severity in percutaneous coronary intervention (PCI) and its impact on short-term clinical outcomes.
    J Clin Med. 2020; 9
    View in Article

    • Google Scholar
29. • Stewart S.
    • Hart C.L.
    • Hole D.J.
    • McMurray J.J.V.
    A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.
    Am J Med. 2002; 113: 359-364
    View in Article

    • Google Scholar
30. • Cha Y.M.
    • Redfield M.M.
    • Shen W.K.
    • Gersh B.J.
    Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle.
    Circulation. 2004; 109: 2839-2843
    View in Article

    • Google Scholar